what does ibrutinib treat
Ibrutinib is approved to treat: 1  Chronic lymphocytic leukemia in patients who have already received other treatment. 2  Mantle cell lymphoma in patients who have already received other treatment. 3  WaldenstrÃ¶m macroglobulinemia (a type of non-Hodgkin lymphoma).